Edesa Biotech is trading at $2.30, up 7.98% in pre-market, with no clear company-specific catalyst identified for the November 6 move.
- The latest company announcement found was November 4: management planned to participate in a healthcare conference on November 9–11; this does not establish a direct cause.
- Supplied market indicators are mixed, so broader-market direction does not clearly explain the gain.